Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Parasitic Diseases

  Free Subscription


1 Am J Trop Med Hyg
2 J Immunol
3 Lancet Infect Dis
2 Parasite Immunol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Trop Med Hyg

  1. SHEN J, Yuan L, Sun Y, Jiang X, et al
    Case Report: Multiple Schistosomiasis Japonica Cerebral Granulomas without Gastrointestinal System Involvement: Report of Two Cases and Review of Literature.
    Am J Trop Med Hyg. 2020 Apr 6. doi: 10.4269/ajtmh.19-0797.
    PubMed         Abstract available

    J Immunol

  2. PARMAR N, Chandrakar P, Kar S
    Leishmania donovani Subverts Host Immune Response by Epigenetic Reprogramming of Macrophage M(Lipopolysaccharides + IFN-gamma)/M(IL-10) Polarization.
    J Immunol. 2020 Apr 10. pii: jimmunol.1900251. doi: 10.4049/jimmunol.1900251.
    PubMed         Abstract available

  3. JHA MK, Sarode AY, Bodhale N, Mukherjee D, et al
    Development and Characterization of an Avirulent Leishmania major Strain.
    J Immunol. 2020 Apr 3. pii: jimmunol.1901362. doi: 10.4049/jimmunol.1901362.
    PubMed         Abstract available

    Lancet Infect Dis

  4. STRESMAN G, Sepulveda N, Fornace K, Grignard L, et al
    Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community da
    Lancet Infect Dis. 2020 Apr 8. pii: S1473-3099(20)30059.
    PubMed         Abstract available

  5. ASHLEY EA, Phyo AP
    Plasmodium falciparum ATP4 inhibitors to treat malaria: worthy successors to artemisinin?
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(20)30139.

  6. GAUR AH, McCarthy JS, Panetta JC, Dallas RH, et al
    Safety, tolerability, pharmacokinetics, and antimalarial efficacy of a novel Plasmodium falciparum ATP4 inhibitor SJ733: a first-in-human and induced blood-stage malaria phase 1a/b trial.
    Lancet Infect Dis. 2020 Apr 7. pii: S1473-3099(19)30611.
    PubMed         Abstract available

    Parasite Immunol

  7. ABU ALSHAMAT E, Kweider M, Abbady AQ
    Camel Nanobodies: Promising Molecular Tools Against Leishmaniasis.
    Parasite Immunol. 2020 Apr 6:e12718. doi: 10.1111/pim.12718.
    PubMed         Abstract available

  8. MAJUMDER N, Ganguly S, Ghosh AK, Kundu S, et al
    Chlorogenic acid acts upon Leishmania donovani arresting cell cycle and modulating cytokines and nitric oxide in vitro.
    Parasite Immunol. 2020 Apr 5:e12719. doi: 10.1111/pim.12719.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.